Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 11:11:70.
doi: 10.1186/1471-2350-11-70.

Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes

Affiliations

Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes

Simon C Ramsden et al. BMC Med Genet. .

Abstract

Background: Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are clinically distinct neurodevelopmental genetic disorders that map to 15q11-q13. The primary phenotypes are attributable to loss of expression of imprinted genes within this region which can arise by means of a number of mechanisms. The most sensitive single approach to diagnosing both PWS and AS is to study methylation patterns within 15q11-q13; however many techniques exist for this purpose. Given the diversity of techniques available, there is a need for consensus testing and reporting guidelines.

Methods: Testing and reporting guidelines have been drawn up and agreed in accordance with the procedures of the UK Clinical Molecular Genetics Society and the European Molecular Genetics Quality Network.

Results: A practical set of molecular genetic testing and reporting guidelines has been developed for these two disorders. In addition, advice is given on appropriate reporting policies, including advice on test sensitivity and recurrence risks. In considering test sensitivity, the possibility of differential diagnoses is discussed.

Conclusion: An agreed set of practice guidelines has been developed for the diagnostic molecular genetic testing of PWS and AS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Genes within the PWS and AS critical region. Blue boxes represent paternally expressed genes; blue vertical lines, snoRNAs; red boxes, maternally expressed genes; black boxes, biallelically expressed genes and arrow heads represent the orientation of transcription. IC, imprinting centre; BP, common breakpoint cluster region.
Figure 2
Figure 2
Testing strategies for the molecular analysis of PWS and AS based upon (i) an initial methylation analysis at the SNRPN locus and (ii) an initial MLPA analysis.
Figure 3
Figure 3
The potential for mis-diagnosis as a result of a Not I restriction site polymorphism in SNRPN exon 1 (i) Genomic organisation. (ii) Southern blot analysis using probe KB17 (lane 1 - PWS; lane 2 - AS; lane 3 - Normal (with Not I polymorphism); lane 4 - Normal).

Similar articles

Cited by

References

    1. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398–402. - PMC - PubMed
    1. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001;108:E92. doi: 10.1542/peds.108.5.e92. - DOI - PubMed
    1. Williams CA, Angelman H, Clayton-Smith J, Driscoll DJ, Hendrickson JE, Knoll JH, Magenis RE, Schinzel A, Wagstaff J, Whidden EM, Zori RT. Angelman syndrome: consensus for diagnostic criteria. Am J Med Genet. 1995;56:237–8. doi: 10.1002/ajmg.1320560224. - DOI - PubMed
    1. Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, Magenis RE, Moncla A, Schinzel AA, Summers JA, Wagstaff J. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2006;140:413–418. - PubMed
    1. Buiting K, Saitoh S, Groß S, Dittrich B, Schwartz S, Nicholls R, Horsthemke B. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet. 1995;9:395–400. doi: 10.1038/ng0495-395. - DOI - PubMed

Substances